Author

C. Climent

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 1 Research Focus:host-pathogen & immune response· 1 Organism:human· 1 Assay:proteomics· 1

Frequent Co-Authors

A. K. Pinto· 1 shared A. M. Espino· 1 shared B. T. Grimberg· 1 shared C. A. Sariol· 1 shared D. F. Hoft· 1 shared E. Geerling· 1 shared E. T. Stone· 1 shared J. D. Brien· 1 shared

Activity by Year

2020-2020 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperImmunology

A. K. Pinto

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

The receptor binding domain of SARS-CoV-2 spike is the key target of neutralizing antibody in human polyclonal sera.

T. Steffen, E. T. Stone, M. Hassert, E. Geerling, B. T. Grimberg, A. M. Espino, P. Pantoja, C. Climent, D. F. Hoft, S. L. George, C. A. Sariol, A. K. Pinto, J. D. Brien

This study identifies the receptor binding domain (RBD) of SARS-CoV-2 spike as the primary target of neutralizing antibodies in human polyclonal sera.

bioRxiv · Aug 21, 2020 · PreprintImmunology